Zhang et al. proved that KL10 was considerably downregulated in NSCLC compared to non-cancer samples. They concluded that KLK10 functions as a tumor suppressor gene in NSCLC, and epigenetic inactivation is a common occurrence in NSCLC pathogenesis that could be exploited as a biomarker (25). This evidence concerns the gene KLK10 and cancer.